Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 289

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 289
---
 date that the financial statements were issued. Based upon
this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or
disclosure in the financial statements.

On July 5, 2025, the
Board of Directors of the Company approved a reverse stock split of all of the Company’s issued and unissued shares, including
the Class A ordinary shares with no par value (the “Class A Ordinary Shares”), Class B ordinary shares with no par value
and preferred shares with no par value, at an exchange ratio of one (1) share for five (5) shares (the “Reverse Stock Split”).
Upon the opening of the market on August 5, 2025, the Company’s Class A Ordinary Shares began trading on the Nasdaq Capital Market
(“Nasdaq”) on a post-Reverse Stock Split basis.

On July 21, 2025, NewGenDigital
Limited (“NewGenDigital”), a wholly owned subsidiary of the Company, signed a Memorandum of Understanding (the “MOU”)
with BNW Real Estate Development LLC (“BNW”), a prominent real estate developer in Ras Al Khaimah and Dubai, UAE. Per the
terms of the MOU, NewGenDigital and BNW will endeavor to negotiate and execute a definitive Joint Venture Agreement to form a special
purpose vehicle with the intention of developing NewGenDigital’s recently acquired strategic plot of land in Ras Al Khaimah’s
Beach District, UAE (“Plot”).

On October 6, 2025, the
Company announced that it has received an independent valuation report from a Big Four global accounting firm of its recently acquired
advanced cytometry intellectual property (the “IP”), the acquisition of which was initially announced on July 29, 2025. The
Report sets the fair value of the IP at US$17.9 million. Together with the fair value of the advanced cytometry equipment and other assets
obtained from this acquisition, the transaction has resulted in an immediate Bargain Purchase Gain for the Company of US$19.2 million.

On October 6, 2025, NewGenProperty
Limited (“NewGenProperty”), a wholly owned subsidiary of the Company, entered into a joint venture agreement with BNW to
develop the Plot. Under the terms of the joint venture agreement, NewGenProperty shall hold 60% of the joint venture, and be responsible
for funding 36% of the purchase price